Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in TCRX — TScan Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$48,117
-$9,986 QoQ
Shares Held
49,100
-14.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 60 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. TCRX ranks #322 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in TCRX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $48,117 49,100
2026-03-31 $58,103 57,529
2025-12-31 $38,700 38,700
2025-09-30 $405,902 223,024
2025-06-30 $316,052 217,967
2025-03-31 $235,082 170,350
2024-12-31 $456,346 150,114
2024-09-30 $484,110 97,211
2024-06-30 $256,124 43,782
2024-03-31 $239,620 30,179
2023-12-31 $220,397 37,804
2023-09-30 $512 200
2023-06-30 $500 200
2023-03-31 $420 200
2022-12-31 $362 234
2021-12-31 $850 189